‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

via Rice University
via Rice University
The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs.

The research, which is available online this week Nature Medicine, reports that Rice’s “quadrapeutics” technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.

Read more . . .

 

The Latest on: Quadrapeutics

[google_news title=”” keyword=”Quadrapeutics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

 

The Latest on: Quadrapeutics
    Feed has no items.

via  Bing News

See Also

 

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top